(unpublished data). Introducing pill counts in these settings would add considerably to the clinic workload.
Pharmacy refill records are commonly used to calculate adherence indicators for other chronic diseases in settings with electronic pharmacy data systems, 13 either as the percentage of days within a defined period covered by medicines dispensed or as the occurrence of gaps in medication supply between refills. For the patient, time without dispensed medicine is by definition a time of nonadherence. Dispensing-based adherence measurement has now been shown to be feasible using the types of manual pharmacy record systems common in resource-poor settings in Africa. 14 In resource-rich environments, poor clinic attendance has been correlated with mortality. 13 Failure to attend clinic when expected is objective information and easy to ascertain in most record systems, even in resource-poor settings, 14, 15 and inconsistent attendance may identify patients in need of outreach or adherence counseling.
At least two groups have responded to the pressing need to develop practical and reliable indicators to monitor adherence and retention: The International Network for the Rational Use of Drugs Initiative on Adherence to ART (INRUD-IAA) 16 and the WHO HIV Drug Resistance Team. 17 In 2006 and 2007, INRUD-IAA country teams tested the feasibility of collecting data on patient appointment keeping and pharmacy refills and calculating indicators in 80 diverse facilities in Kenya, Rwanda, Uganda, and Ethiopia. 14 These indicators were shown to predict weight gain and increased CD4 counts in newly treated patients (unpublished data). The WHO HIV Drug Resistance Team has developed a series of indicators to provide an early warning about possible development of resistance to ART, including indicators addressing adherence based on pharmacy refill and appointment keeping. 17 The suggested adherence indicators from these two teams are listed in Table 1 . Enough evidence now exists to show that it is feasible for facilities at all levels to collect dispensing and attendance data and calculate adherence and retention indicators.
Recently, the Global Fund became the first funding organization to recommend an adherence indicator to monitor program performance. 5 This is a welcome beginning. International organizations and national AIDS control programs have a clear and urgent need to finalize agreement about standard indicators to monitor patient adherence and retention and to begin to make such data publicly available. UNAIDS and the WHO Department of HIV/AIDS should take the lead in coordinating donor and country collaboration in this important endeavor. 
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